Pharmaceutical Export from India | Medicines, Drugs & Bulk Supply
Pharmaceutical Export from India | Nawinza OPC
Nawinza OPC provides pharmaceutical sourcing and export coordination services from India for international buyers seeking pharmaceutical products, commercial supply opportunities, and business-to-business procurement solutions. We aim to connect eligible buyers with suitable Indian pharmaceutical manufacturers, authorised suppliers, and exporters, subject to product availability, applicable licences, destination-country regulations, and mutually agreed commercial terms.
Our pharmaceutical export services are designed for importers, distributors, wholesalers, pharmaceutical companies, healthcare procurement organisations, and other eligible business buyers looking to source medicines from India for authorised commercial use.
We support product enquiries, specification confirmation, supplier coordination, quotation preparation, export documentation coordination, shipment planning, and communication between buyers and relevant suppliers.
Website: www.nawinza.com
Email: nawinza2026@gmail.com
WhatsApp / Mobile: +91 7709102335
Business: Nawinza OPC Pvt Ltd
Business activity: Pharmaceutical sourcing, export coordination, and B2B supply enquiries from India.
Important: Product availability, manufacturer identity, brand authorisation, regulatory approvals, applicable licences, and export eligibility must be confirmed for each transaction. An enquiry or quotation does not itself constitute a confirmed order, a regulatory approval, or a guarantee of product availability.
Pharmaceutical Products and Categories
Nawinza OPC accepts business enquiries for pharmaceutical products across relevant dosage forms and therapeutic categories, subject to applicable laws, supplier authorisation, export eligibility, and destination-market requirements.
Tablets, Capsules, Syrups, Injections and Other Dosage Forms
Buyers should specify the exact product, active ingredient, strength, dosage form, pack size, requested brand or manufacturer, destination country, and required quantity.
Potential dosage forms include:
Tablets: Conventional, film-coated, sugar-coated, dispersible, chewable, and other approved tablet forms.
Capsules: Hard-gelatin, HPMC, and other capsule formats, where available.
Syrups and oral liquids: Syrups, oral solutions, suspensions, and other suitable liquid formulations.
Injections: Sterile injectable formulations, including relevant ampoule, vial, and prefilled presentation formats, subject to strict product-specific requirements.
Creams, ointments and gels: Topical pharmaceutical preparations.
Eye, ear and nasal preparations: Drops, sprays, and other authorised formulations.
Powders and granules: Oral powders, sachets, granules, and other suitable pharmaceutical presentations.
Other pharmaceutical forms: Suppositories, inhalation products, transdermal preparations, and other products where legally eligible and available.
The above list identifies possible product categories for enquiry. It does not confirm that every formulation, brand, strength, or pack size is currently available for export.
Pharmaceutical Therapeutic Categories
Enquiries may cover relevant therapeutic groups, including:
Anti-infective medicines, including antibiotics and antivirals, where legally permitted.
Cardiovascular medicines.
Diabetes and metabolic care medicines.
Gastrointestinal medicines.
Pain management and anti-inflammatory medicines.
Respiratory and allergy medicines.
Dermatological preparations.
Vitamins, minerals, and nutritional products classified as medicines in the relevant market.
Neurological and other specialist medicines.
Hospital and critical-care pharmaceutical products, where applicable.
Other approved pharmaceutical products specified by the buyer.
Product classification depends on the formulation, composition, intended use, and laws of the importing country. Medicines subject to controlled-drug rules, special import permissions, or additional restrictions require separate verification and may not be eligible for supply.
Product Strength, Pack Size and Specifications
To minimise quotation errors, buyers should provide complete product specifications.
Each enquiry should identify:
Generic name or active pharmaceutical ingredient (API): The active ingredient required.
Brand name: The requested trade name, if a specific brand is necessary.
Strength: The amount or concentration of active ingredient, such as mg per tablet, mg per capsule, mg/5 mL, or another appropriate unit.
Dosage form: Tablet, capsule, syrup, suspension, injection, cream, or another specified form.
Pack size: Number of units per strip, blister, bottle, vial, carton, or other saleable pack.
Manufacturer: The requested manufacturer or an acceptable alternative, if permitted.
Quantity: The number of saleable packs, boxes, bottles, strips, or units required.
Shelf-life requirement: The minimum remaining shelf life required at dispatch or arrival.
Storage conditions: Ambient, refrigerated, frozen, light-protected, or other applicable requirements.
Destination: Country and, where necessary, the final delivery city or port.
Regulatory requirements: Product registration, import permits, labelling, language, and other applicable conditions.
Required documentation: Applicable certificates, product information, batch documents, and shipment documents.
The parties should agree on the exact product specification in writing before order confirmation. A product should not be substituted with another brand, manufacturer, strength, formulation, or pack size without the buyer’s prior written approval.
Brand, Manufacturer and Batch-Specific Verification
Buyers may request information necessary to evaluate a proposed product and supplier, subject to availability, confidentiality, applicable law, and the relevant supplier’s authorisation.
Depending on the product and destination, verification may include:
Manufacturer’s legal name and manufacturing-site details.
Product registration or marketing authorisation details, where applicable.
Relevant manufacturing licence and applicable GMP evidence.
Product specification and approved label information.
Batch number and manufacturing or expiry dates, once the specific batch is allocated.
Certificate of Analysis (CoA), where available and appropriate.
Certificate of Pharmaceutical Product (CoPP), where applicable and obtainable.
Storage and transportation requirements.
Confirmation of brand ownership, distribution rights, or authorisation when required.
A manufacturer’s name, a certificate, a website listing, or a product photograph alone does not establish that a particular batch is authentic, approved for import, or authorised for sale in the destination country. Batch-level documents and their validity should be verified with the issuing manufacturer or competent authority where appropriate.
Pharmaceutical Sourcing and Export Process
Nawinza OPC follows a transaction-based process intended to clarify product requirements, supplier suitability, regulatory conditions, and commercial responsibilities before shipment.
Step 1: Buyer Enquiry
The buyer submits a written enquiry containing the product name, strength, dosage form, brand preference, quantity, destination country, delivery requirements, and required documents.
Incomplete enquiries may require additional clarification before pricing can be prepared.
Step 2: Product and Supplier Assessment
The proposed product and supply route are assessed against availability, supplier capability, product specifications, required authorisations, and export eligibility.
Supplier identification and verification are performed to the extent agreed for the transaction. Buyers may request relevant supporting documents before committing to an order.
Step 3: Regulatory Feasibility
The buyer and seller identify the applicable import requirements and confirm which party is responsible for obtaining product registration, import licences, permits, and other approvals.
No shipment should proceed until required approvals and permissions have been obtained and the proposed transaction is legally permissible.
Step 4: Quotation and Commercial Review
A written quotation identifies the proposed product, manufacturer or brand where confirmed, quantity, price, currency, quotation validity, delivery term, estimated lead time, payment schedule, and included or excluded costs.
All estimates and conditions must be clearly distinguished from confirmed information.
Step 5: Purchase Order and Order Acceptance
The buyer issues a purchase order (PO) or other written order document. The seller confirms acceptance in writing after reviewing product specifications, availability, pricing, regulatory conditions, and payment terms.
An order is considered commercially confirmed only when the parties have agreed to the essential terms and satisfied any stated conditions precedent.
Step 6: Supplier Procurement and Quality Documentation
The responsible supplier arranges the agreed products and provides the documentation required under the purchase agreement, subject to the applicable regulatory framework.
Where relevant, the buyer and seller confirm product release, batch information, packaging, labelling, and remaining shelf life before dispatch.
Step 7: Export Documentation and Shipment
The responsible exporter, customs broker, freight forwarder, and other appointed parties coordinate export clearance, shipping arrangements, and required documentation.
The shipment must comply with applicable Indian export rules, customs procedures, destination-country import requirements, and product-specific restrictions.
Step 8: Delivery, Inspection and Closure
The buyer or designated consignee receives the shipment according to the agreed delivery term and checks the goods and documents within the agreed inspection period.
Shortages, transit damage, temperature excursions, incorrect products, or documentary discrepancies should be reported promptly with supporting evidence. The parties then follow the agreed claims, corrective-action, replacement, refund, or other remedy procedure, subject to the contract and applicable law.
Pharmaceutical Export Documentation and Compliance
Pharmaceutical exports require more than a commercial invoice and transport document. Requirements depend on the product, manufacturer, exporter, importing country, transport mode, and the transaction’s regulatory classification.
Indian Export Requirements
Depending on the transaction, the responsible Indian exporter may need to confirm:
Import Export Code (IEC), where required.
Applicable GST registration and tax treatment.
Correct export classification and customs declaration.
Commercial invoice and packing list.
Shipping bill and applicable customs clearance records.
Bill of lading or air waybill, as relevant.
Certificate of Origin, if required or agreed.
Applicable product-specific export permissions or restrictions.
Foreign-exchange and payment realisation requirements under applicable Indian law.
Relevant export incentive or tax documentation, if claimed and applicable.
A pharmaceutical product may require additional permissions, licences, or conditions depending on its classification. The existence of an IEC alone does not authorise the export of every medicine.
Destination-Country Import Requirements
The buyer or its authorised local importer should establish the requirements of the importing country’s competent authority before placing a binding order.
These may include:
Importer registration and authorisation.
Product registration or marketing authorisation.
Import permit or consignment-specific approval.
Manufacturer or manufacturing-site approval.
GMP evidence or inspection requirements.
Approved labelling, package inserts, and language requirements.
Batch-specific documentation or testing.
Customs classification and applicable duties and taxes.
Pharmacovigilance, traceability, serialisation, or other local obligations, where applicable.
The buyer is generally responsible for local import permissions and market-entry obligations unless the written contract lawfully assigns a specific responsibility elsewhere. The exporter remains responsible for the obligations applicable to its own role.
Product Quality and Good Manufacturing Practices
Where applicable, pharmaceutical products should be sourced from suitably authorised manufacturers and handled according to the product’s quality, storage, and distribution requirements.
Depending on the transaction, relevant evidence may include:
Good Manufacturing Practice (GMP) documentation.
Good Distribution Practice (GDP) evidence, where applicable.
Product registration or marketing authorisation.
Certificate of Analysis (CoA).
Certificate of Pharmaceutical Product (CoPP), where applicable.
Stability and shelf-life information.
Batch release or other quality documentation, where required.
Not every certificate is required for every product or country. The buyer and seller should agree on the specific documents required and confirm that they are available and acceptable before dispatch.
Product Registration and Importer Authorisation
Product registration is the approval or authorisation process required by the relevant national regulator for a medicine to be marketed or supplied in that country.
An import permit is a separate permission to import a product or consignment where local law requires it.
A product registered in India is not automatically authorised in another country. Similarly, a manufacturer’s GMP status does not by itself establish that a product has marketing authorisation in the buyer’s country.
The buyer should not assume that a quotation or supply commitment guarantees successful product registration, customs release, or market approval.
Special Categories and Restricted Products
Products containing controlled substances, narcotic or psychotropic ingredients, certain biological materials, cold-chain medicines, investigational products, or other specially regulated substances may require additional permissions or may be restricted.
Such products must be assessed individually. No order should be accepted or shipped without confirmation that the product, exporter, importer, route, and intended use are legally eligible.
Pharmaceutical Products and Categories Tablets, Capsules, Syrups, Injections and Other Forms
Pharmaceutical Export Policy from India
Pharmaceutical export transactions must comply with the laws and regulatory requirements in force in India and the destination country on the relevant transaction and shipment dates.
The principal regulatory framework may include the following, as applicable:
Directorate General of Foreign Trade (DGFT): India’s Foreign Trade Policy, ITC (HS) export classification, export authorisations, and applicable export restrictions.
Central Drugs Standard Control Organisation (CDSCO): Applicable Indian drug regulatory requirements and relevant product or manufacturing authorisations.
State Drug Control Authorities: Applicable manufacturing, wholesale, and other drug licences within their respective jurisdictions.
Central Board of Indirect Taxes and Customs (CBIC): Customs procedures, export declarations, and applicable customs requirements.
Goods and Services Tax (GST) authorities: Applicable GST rules and export-related tax procedures.
Reserve Bank of India (RBI) and authorised dealer banks: Applicable foreign-exchange and export payment requirements.
Destination-country regulatory authorities: Local pharmaceutical registration, import permissions, product standards, and market-entry rules.
The precise obligations depend on the transaction. Buyers and sellers should consult the relevant authorities, licensed customs brokers, regulatory specialists, or legal advisers when necessary.
Export Policy and Product Eligibility
Before confirming an order, the responsible parties should establish:
Whether the product is freely exportable, restricted, prohibited, or subject to specific authorisation.
Whether the proposed exporter and supplier hold the licences required for their respective activities.
Whether the importing entity is authorised to import the product.
Whether the destination country permits the proposed product, brand, strength, manufacturer, and intended use.
Whether special permissions are needed for controlled medicines, biological products, temperature-sensitive products, or other regulated categories.
Whether the packaging, labelling, shelf life, and documentation meet applicable requirements.
Whether any sanctions, trade restrictions, customs restrictions, or payment restrictions apply to the transaction.
Compliance principle: Neither party should request, offer, pay for, or proceed with a transaction that would violate applicable law. Where an approval is outstanding, the parties should identify it as a condition to order acceptance, procurement, payment, or shipment, as appropriate.
Bulk Pharmaceutical Orders, Quotations and Shipping
Nawinza OPC welcomes B2B enquiries for bulk pharmaceutical requirements, subject to product availability, minimum order quantities, regulatory feasibility, and supplier terms.
Information Required for a Bulk Quotation
For a faster and more accurate quotation, the buyer should provide:
Product name and generic name.
Brand and manufacturer preference.
Strength and dosage form.
Pack size and packaging requirements.
Required quantity and unit of measurement.
Destination country, city, and delivery location or port.
Required registration or import authorisation details, where applicable.
Minimum remaining shelf-life requirement.
Required certificates and shipping documents.
Preferred Incoterm, if already determined.
Preferred payment method and proposed delivery schedule.
Special storage, temperature-control, labelling, or handling requirements.
What a Pharmaceutical Quotation Should Include
A written quotation should clearly state:
| Quotation field | What it means |
|---|---|
| Product description | Exact medicine, strength, form, and pack size |
| Manufacturer and brand | Confirmed supplier and product identity, where available |
| Quantity | Number of packs, boxes, units, or other agreed measurement |
| Unit price | Price per agreed saleable unit |
| Total product value | Quantity multiplied by the agreed unit price |
| Currency | USD, EUR, INR, or another mutually agreed currency |
| MOQ | Minimum order quantity, if applicable |
| Lead time | Estimated or confirmed period before dispatch |
| Quotation validity | Date until which the offer remains valid |
| Incoterm | Agreed allocation of delivery obligations, costs, and risks |
| Freight and insurance | Included or excluded shipping costs and insurance |
| Duties and taxes | Party responsible for import duties, VAT/GST, and other charges |
| Payment terms | Deposit, advance payment, balance payment, or agreed credit terms |
| Documentation | Certificates and shipping records included in the offer |
| Conditions | Regulatory approvals, availability, shelf life, and other prerequisites |
A quotation is an offer on stated terms, not proof that stock has been reserved. Stock availability, price, delivery schedule, and supplier conditions should be reconfirmed before the order is accepted.
Incoterms: EXW, FCA, FOB, CFR, CIF and DAP
Incoterms are internationally recognised rules that help define the delivery responsibilities, costs, and risk allocation between a seller and a buyer. The parties should identify the chosen rule, named place or port, and the applicable Incoterms edition in the contract.
| Term | General explanation |
|---|---|
| EXW — Ex Works | The seller makes the goods available at the agreed location; the buyer assumes extensive collection and transport responsibilities. |
| FCA — Free Carrier | The seller delivers the goods to the carrier or other nominated party at the agreed place under the rule’s conditions. |
| FOB — Free on Board | Generally used for sea or inland-waterway transport; the seller delivers the goods on board the nominated vessel at the agreed port. |
| CFR — Cost and Freight | For sea or inland-waterway transport; the seller pays freight to the named destination port, while risk transfers under the rule at the port of shipment. |
| CIF — Cost, Insurance and Freight | For sea or inland-waterway transport; the seller pays freight and obtains the insurance required by the rule, while risk transfers at the port of shipment. |
| DAP — Delivered at Place | The seller arranges delivery to the named destination, ready for unloading; the buyer generally handles import clearance and import duties and taxes. |
The above are general descriptions, not a substitute for the full rules. For containerised cargo, FCA may be more appropriate than FOB depending on how the goods are handed over. Under CIF, insurance cover is not the same as a guarantee against every loss, and the buyer should check the required cover and any additional insurance needs.
For every quotation, state the exact named place or port, for example, “CIF [named destination port], Incoterms® 2020,” where appropriate.
Shipping Costs and Landed Cost
The buyer should assess the complete landed cost, rather than the product price alone.
A landed-cost estimate may include:
Product price.
Export packing and handling, if separately charged.
Inland transportation in India.
Export customs clearance and applicable charges.
Freight and cargo insurance, depending on the agreed Incoterm.
Destination terminal and handling charges.
Customs duties and other import charges.
Import VAT/GST or similar taxes.
Customs broker, inspection, storage, and delivery charges.
Bank charges, foreign-exchange costs, and other agreed expenses.
Actual amounts depend on the destination, product classification, shipment size, route, and contract. Estimated charges should be labelled as estimates and reconfirmed with the relevant service providers or authorities.
Payment Terms and Commercial Security
Payment terms must be agreed in writing before the order is confirmed. The appropriate arrangement depends on the transaction value, buyer and seller history, banking availability, supplier conditions, and risk allocation.
Potential arrangements include:
Advance payment: Payment is made before procurement or shipment, according to the contract.
Deposit and balance: An agreed deposit is paid at order confirmation, with the balance payable at a specified milestone.
Documentary collection: Banks handle documents according to collection instructions but generally do not guarantee payment.
Letter of Credit (LC): A bank undertakes payment subject to the LC’s terms and compliant document presentation.
Open-account terms: Payment is made after an agreed credit period; this requires clear credit approval and risk assessment.
Other agreed payment arrangements: Permitted methods accepted by the parties and their banks.
The purchase agreement should identify the currency, bank charges, payment milestones, beneficiary details, due dates, late-payment consequences, refund conditions, and the procedure for handling discrepancies.
Buyers should verify the seller’s legal identity and independently confirm bank-account changes using a previously verified contact method. Do not rely solely on emailed instructions to change beneficiary details.
Pharmaceutical Quality, Packaging and Shelf Life
Pharmaceutical quality requirements should be agreed before procurement and documented in the purchase order or quality agreement, where appropriate.
The parties should confirm:
The precise product, manufacturer, and approved specification.
The applicable quality standard and release requirements.
The permitted packaging configuration and labelling.
The minimum remaining shelf life at dispatch or delivery.
Required batch-specific records and certificates.
Applicable storage and transport conditions.
Temperature monitoring and excursion procedures for temperature-sensitive products.
Traceability and recall communication arrangements.
Procedures for reporting damaged, defective, incorrect, or suspect products.
The buyer should not change the product’s packaging, label, storage conditions, or intended market without the necessary authorisations. Relabelling, repackaging, and private-label supply require separate feasibility and regulatory assessment.
Cold-Chain and Temperature-Sensitive Products
Products requiring controlled temperatures need appropriate packaging, validated or otherwise suitable transport arrangements, and temperature monitoring where required by the product and applicable regulations.
The contract should specify the permitted temperature range, monitoring evidence, delivery handover, excursion notification, investigation procedure, and the authority responsible for determining product disposition after a temperature deviation.
A shipment should not be considered acceptable merely because its external packaging appears undamaged.
Buyer and Seller Responsibilities
Clear responsibilities reduce disputes and delays. The final allocation must be documented in the purchase agreement.
Buyer’s Responsibilities
The buyer should:
Provide complete and accurate product specifications and quantity requirements.
Supply valid business, importer, and regulatory details where required.
Confirm destination-country registration, import permits, and local legal eligibility.
Specify required labelling, language, packaging, certificates, and shelf-life criteria.
Review the quotation, Incoterm, freight arrangements, and landed-cost assumptions.
Make payments according to the agreed schedule.
Appoint the relevant customs broker, importer, or consignee where required.
Arrange import clearance and pay import charges allocated to the buyer.
Inspect received products and documents within the agreed period.
Report discrepancies, damage, or suspected quality issues promptly.
Store and distribute products in accordance with applicable requirements after delivery.
Avoid resale or distribution in markets where the product is not authorised.
Seller’s Responsibilities
The seller should:
Accurately describe the offered product and clearly identify any unconfirmed details.
Confirm the supplier’s ability to fulfil the order and the availability of the agreed specification.
Hold or arrange the licences and authorisations applicable to the seller’s role.
Disclose relevant regulatory, availability, and shipment conditions before order acceptance.
Supply the products agreed in the purchase order.
Provide the documentation expressly agreed and required for the seller’s responsibilities.
Arrange export clearance and transport obligations allocated to the seller.
Use appropriate packaging and handling for the product and agreed transport conditions.
Communicate material changes, delays, shortages, and compliance issues promptly.
Cooperate in investigating substantiated product, packaging, or shipment discrepancies.
Protect confidential buyer and supplier information, subject to legal requirements.
Avoid making unsupported claims about approvals, certifications, authenticity, or delivery guarantees.
The term “seller” in a contract should identify the actual contracting entity. Nawinza OPC’s responsibilities will depend on whether it acts as the seller of record, an authorised exporter, a sourcing coordinator, or another expressly agreed capacity. The parties should not assume that Nawinza manufactures, owns, or directly supplies every product listed for enquiry.
Purchase Order, Supply Agreement and Quality Agreement
For repeat, high-value, regulated, or otherwise complex transactions, the parties should consider a written supply agreement supported by a product specification and, where appropriate, a quality agreement.
The commercial documents should address the following matters:
1. Parties and Authority
Record each party’s full legal name, registered address, business registration details where applicable, authorised representative, and notice contact details.
Each party should confirm that its signatory has authority to enter into the agreement.
2. Product and Quantity
List the product name, active ingredient, strength, dosage form, brand, manufacturer, pack size, quantity, unit of measurement, agreed specifications, and any approved alternatives.
3. Price and Currency
State the unit price, total order value, currency, applicable taxes, freight, insurance, bank charges, and any other agreed costs.
4. Payment and Order Confirmation
Specify the deposit, payment milestones, invoice requirements, due dates, payment method, and conditions under which procurement or shipment may begin.
5. Delivery and Risk
Identify the delivery location, Incoterm and edition, shipping method, target dispatch date, estimated transit period, and allocation of transport costs and risk.
6. Regulatory Conditions
Identify the approvals, registrations, licences, certificates, and permits needed before procurement, export, import, or distribution.
State who is responsible for obtaining each item and what happens if an approval is delayed, denied, suspended, or withdrawn.
7. Documentation
List the documents required from the seller, supplier, buyer, freight forwarder, or other responsible party, including their format and timing.
8. Inspection and Acceptance
Define the inspection period, permitted inspection methods, evidence required for a claim, and the process for identifying shortages, transit damage, specification discrepancies, or documentation defects.
9. Defects, Complaints and Recalls
Specify notification timelines, investigation procedures, quarantine or segregation requirements, recall cooperation, corrective action, and any agreed replacement, credit, or refund remedy.
10. Cancellation and Refunds
State when cancellation is permitted, how supplier commitments and non-recoverable costs are treated, and when refunds are due. Refunds and deductions should follow the contract and applicable law.
11. Confidentiality and Intellectual Property
Protect non-public pricing, customer details, supplier information, technical documents, trademarks, and other confidential information. Specify permitted disclosures and any applicable confidentiality period.
12. Liability and Dispute Resolution
Define any legally permissible liability limits, indemnities, governing law, dispute-resolution procedure, jurisdiction or arbitration arrangements, and notice requirements.
13. Force Majeure
Address events beyond a party’s reasonable control, the requirement to notify the other party, mitigation measures, and the effect on performance or termination.
14. Contract Documents and Amendments
Identify the controlling purchase order, quotation, supply agreement, quality agreement, and any applicable annexes. State how inconsistencies are resolved and require written approval for material changes.
Important: A website enquiry, email quotation, pro forma invoice, purchase order, and signed supply agreement may have different legal effects. Their effect depends on the wording, acceptance, applicable law, and circumstances. The parties should establish which documents form the binding contract and seek legal review for significant transactions.
Pharmaceutical Export Terms and Definitions
| Term | Meaning |
|---|---|
| API | Active Pharmaceutical Ingredient: the ingredient responsible for the intended pharmacological activity. |
| Generic medicine | A medicine identified by its active ingredient rather than solely by a particular brand; legal equivalence and substitution rules depend on the market. |
| Brand / trade name | The commercial name under which a medicine is marketed. |
| Strength | The amount or concentration of an active ingredient in a defined unit or volume. |
| Dosage form | The physical pharmaceutical form, such as tablet, capsule, injection, syrup, or cream. |
| MOQ | Minimum Order Quantity: the smallest order quantity accepted under the supplier’s terms. |
| PO | Purchase Order: a document specifying the products and commercial terms requested by a buyer. |
| PI | Pro Forma Invoice: a preliminary commercial document setting out proposed transaction details; its legal effect depends on the circumstances. |
| Commercial invoice | A document describing the sale and its value for commercial and customs purposes. |
| Packing list | A document detailing the contents, quantities, and packaging of a shipment. |
| IEC | Importer Exporter Code used for Indian import/export activities where required. |
| HS / ITC (HS) code | A customs classification code used to identify goods; the correct code depends on the product and applicable tariff rules. |
| GMP | Good Manufacturing Practice: quality-system requirements for the manufacture of medicinal products. |
| GDP | Good Distribution Practice: controls supporting appropriate storage and distribution of medicinal products where applicable. |
| CoA | Certificate of Analysis: a document reporting specified test results for a material or batch. |
| CoPP | Certificate of Pharmaceutical Product: a certificate used in relevant pharmaceutical regulatory processes where applicable. |
| Marketing authorisation | Regulatory permission to market a medicinal product in a specified jurisdiction. |
| Import permit | A permission required by certain countries or for particular products before importation. |
| Batch / lot number | An identifier linking a product quantity to a defined manufacturing or packaging batch. |
| Shelf life | The period during which a product is expected to remain within its approved specifications under stated storage conditions. |
| Expiry date | The date after which a product must not be used under the applicable product requirements. |
| Incoterms | International rules defining specified delivery obligations, costs, and risk allocation between buyers and sellers. |
| FOB | Free on Board; a sea or inland-waterway delivery rule with a defined transfer of risk and allocation of obligations. |
| CIF | Cost, Insurance and Freight; a sea or inland-waterway rule under which the seller pays specified freight and insurance while risk transfers at the shipment port. |
| Landed cost | The total cost of obtaining goods at the destination, including relevant transport, duties, taxes, and other charges. |
| Letter of Credit | A bank undertaking to pay against presentation of documents that comply with the credit’s terms. |
| Cold chain | Controlled-temperature storage and transportation maintained as required for a product. |
| Traceability | The ability to identify and follow a product through relevant supply and distribution stages. |
| Pharmacovigilance | Activities concerned with detecting, assessing, understanding, and preventing adverse effects and other medicine-related safety problems. |
| Recall | An action to remove or correct a product when required because of a safety, quality, regulatory, or other qualifying concern. |
| Private label | A product marketed under a buyer’s or another brand owner’s label, subject to authorisation, contractual rights, and regulatory requirements. |
| OEM | Original Equipment Manufacturer; the exact arrangement varies and must be defined in the supply contract. |
| MOQ / lead time | MOQ concerns the minimum order; lead time is the period required to fulfil an order or reach an agreed milestone. |
| Force majeure | A contract provision addressing specified exceptional events beyond a party’s reasonable control. |
Pharmaceutical Export from India Pharmaceutical Export Documentation and Compliance
Frequently Asked Questions (FAQs) — Pharmaceutical Export from India
1. What is pharmaceutical export from India?
Pharmaceutical export from India means supplying eligible medicines and pharmaceutical products from India to overseas buyers in accordance with applicable Indian export laws, destination-country import regulations, and the agreed commercial terms.
2. Does Nawinza OPC provide pharmaceutical export services?
Nawinza OPC accepts pharmaceutical sourcing and export-related B2B enquiries and coordinates requirements according to the agreed scope of each transaction. The contracting entity, supplier, exporter of record, and each party’s responsibilities should be confirmed before an order is placed.
3. Which countries can buyers import pharmaceutical products from India to?
The destination depends on the product, local registration requirements, import permissions, trade restrictions, and the exporter’s eligibility. Buyers should specify their destination country so the relevant requirements can be assessed before order confirmation.
4. Which pharmaceutical products can be requested for export?
Buyers can enquire about tablets, capsules, syrups, suspensions, injections, creams, ointments, drops, and other pharmaceutical dosage forms. Availability and export eligibility must be verified for the specific product and destination.
5. Can international buyers request generic medicines?
Yes, buyers may enquire about generic medicines, subject to availability, product specifications, intellectual-property considerations, and local regulatory requirements. The buyer should identify the active ingredient, strength, dosage form, and any applicable registration requirements.
6. Can buyers request specific pharmaceutical brands?
Yes. Buyers should provide the brand name, manufacturer, strength, dosage form, pack size, and destination. Brand availability, supply authorisation, and applicable trademark or distribution restrictions must be checked before confirmation.
7. Can buyers request a particular manufacturer?
Yes. The buyer can specify a preferred manufacturer. Supply is subject to the manufacturer’s availability, authorisation, export eligibility, and willingness to fulfil the order.
8. What is the minimum order quantity for pharmaceutical exports?
There is no universal minimum order quantity for all medicines. MOQ depends on the product, manufacturer, packaging, production requirements, commercial terms, and destination. The applicable MOQ should be confirmed in the quotation.
9. Can a buyer place a bulk pharmaceutical order?
Bulk enquiries can be considered based on product availability, order size, manufacturer capacity, regulatory conditions, and shipping feasibility. Large orders may require additional documentation, lead time, and commercial approvals.
10. What information must a buyer provide to receive a quotation?
The buyer should provide the product name, strength, dosage form, brand or manufacturer preference, quantity, pack size, destination country, required documents, minimum shelf life, and preferred delivery terms.
11. How can an overseas buyer request a pharmaceutical quotation?
The buyer can contact Nawinza OPC through www.nawinza.com, nawinza2026@gmail.com, or WhatsApp at +91 7709102335. The enquiry should contain complete product and destination details so availability and pricing can be assessed.
12. How long does it take to receive a quotation?
The time depends on the completeness of the enquiry, supplier response, product availability, and regulatory requirements. A quotation timeline should be agreed for each enquiry rather than assumed.
13. What is the difference between a quotation and a confirmed order?
A quotation describes an offer and its conditions. A confirmed order requires acceptance of the essential commercial terms, subject to any stated conditions. The parties should obtain written confirmation before proceeding with procurement or shipment.
14. What is a pro forma invoice?
A pro forma invoice is a preliminary document showing proposed transaction details such as product, quantity, price, currency, and delivery terms. It is often used during order preparation or payment arrangements, but its legal effect depends on its wording and applicable law.
15. What is a purchase order?
A purchase order is a document issued by the buyer specifying the products, quantities, prices, and other requested terms. Whether it creates a binding contract depends on the circumstances and applicable law.
16. Is an advance payment required?
Payment requirements depend on the seller’s terms and the transaction. The parties may agree on advance payment, a deposit and balance, documentary credit, or another lawful arrangement. All payment milestones should be documented before payment.
17. Which currencies can be used for pharmaceutical exports?
The currency depends on the agreed quotation, the parties’ banking arrangements, and applicable foreign-exchange rules. USD and other permitted currencies may be considered where available and lawful.
18. What are Incoterms?
Incoterms are internationally recognised rules that define specified responsibilities, costs, and risk allocation between buyers and sellers. The parties should specify the chosen rule, named place or port, and applicable edition in their agreement.
19. What is the difference between FOB and CIF?
FOB and CIF are sea and inland-waterway transport rules. Under FOB, the seller delivers the goods on board the nominated vessel. Under CIF, the seller also pays freight and obtains the insurance required by the rule for the named destination port. Under both rules, risk generally transfers when the goods are on board at the shipment port.
20. Does CIF include destination import duties and taxes?
Normally, CIF does not include the buyer’s import customs clearance, import duties, import VAT/GST, or all destination handling and delivery charges. The quotation and contract should specify any additional costs included.
21. Who pays customs duty in the importing country?
The responsible party depends on the agreed Incoterm and contract. Under common arrangements such as FCA, FOB, and CIF, the buyer generally handles import clearance and import duties. Under DAP, the buyer generally handles import clearance and import duties and taxes. Other arrangements must be checked against the applicable rule.
22. What documents are required for pharmaceutical exports from India?
Depending on the transaction, documents may include the commercial invoice, packing list, shipping bill, transport document, Certificate of Origin, relevant licences, product certificates, and batch documentation. Not every document is required for every shipment.
23. Is an Import Export Code mandatory?
An IEC is generally required for Indian import/export activities unless a specific exemption applies. The responsible exporter should confirm its eligibility and applicable requirements before proceeding.
24. Is a drug licence required to export medicines from India?
Applicable drug licences and authorisations depend on the product, the activities performed, and the party’s role. An IEC alone does not authorise every pharmaceutical activity. The exporter, supplier, and other responsible entities should confirm their respective requirements with the relevant authorities.
25. Does a medicine approved in India automatically qualify for export to every country?
No. Destination-country registration, marketing authorisation, import permits, manufacturer approvals, labelling rules, and other requirements may apply. Each product and destination must be assessed individually.
26. What is a Certificate of Analysis?
A Certificate of Analysis reports specified test results for a material or batch against relevant quality specifications. Buyers should verify that the document corresponds to the relevant product and batch and is issued by an appropriate source.
27. What is a Certificate of Pharmaceutical Product?
A Certificate of Pharmaceutical Product is used in certain pharmaceutical regulatory procedures. Its applicability, issuing authority, and acceptability depend on the product and destination-country requirements.
28. What is GMP certification?
Good Manufacturing Practice relates to systems and controls used to manufacture medicinal products to appropriate quality standards. The buyer should verify the relevant manufacturing site’s status and determine whether the evidence satisfies the destination regulator’s requirements.
29. Can the buyer request batch number and expiry details before shipment?
The buyer may request the available batch information before shipment. Specific batch numbers and expiry dates can be confirmed when a batch has been allocated and the corresponding records are available.
30. Can the buyer specify minimum remaining shelf life?
Yes. The buyer should specify the minimum remaining shelf life required at dispatch or delivery. The seller should confirm the agreed threshold in writing before order acceptance.
31. Who is responsible for product registration in the destination country?
The buyer or authorised local importer is commonly responsible for local registration and import authorisation unless another lawful arrangement is expressly agreed. The parties should identify the responsible entity and required approvals before shipment.
32. Can an unregistered medicine be imported?
This depends on the destination country’s laws and any applicable exemptions, special access procedures, or consignment-specific permissions. The parties must verify the legal basis before accepting an order or arranging shipment.
33. Can pharmaceutical products be exported under a private label?
Private-label supply may be possible where the manufacturer, brand owner, exporter, importer, and product meet applicable legal and regulatory requirements. Labelling, product registration, intellectual-property rights, manufacturing responsibilities, and quality arrangements must be agreed separately.
34. Can a buyer request OEM pharmaceutical manufacturing?
OEM arrangements may be considered where the relevant manufacturer is authorised and the proposed arrangement is legally permissible. The parties must agree on manufacturing responsibilities, specifications, ownership of intellectual property, quality assurance, labelling, and regulatory submissions.
35. Are injectable medicines subject to additional requirements?
Injectable products are sterile pharmaceutical preparations and may have stringent manufacturing, quality, packaging, storage, transport, and regulatory requirements. The exact requirements depend on the product and destination.
36. Can refrigerated or cold-chain medicines be exported?
Potentially, where the product is eligible and suitable temperature-controlled storage, packaging, transport, monitoring, and documentation can be arranged. Feasibility must be confirmed before order acceptance.
37. What happens if the product is damaged during transport?
The parties should follow the agreed delivery term, insurance arrangements, inspection period, evidence requirements, and claims procedure. Photographs, packaging records, temperature records, transport documents, and other relevant evidence may be needed.
38. What happens if the buyer receives the wrong strength or product?
The buyer should notify the seller within the agreed inspection or notification period and provide evidence of the discrepancy. The parties should follow the contract’s investigation and remedy provisions. The buyer should not use or distribute a product suspected of being incorrect or non-compliant.
39. Can an order be cancelled after payment?
Cancellation and refunds depend on the contract, procurement status, supplier commitments, applicable law, and the reason for cancellation. The parties should agree on cancellation conditions and refund timelines before payment.
40. Can a seller change the brand or manufacturer after order confirmation?
A material change should not be made without the buyer’s prior written approval and any required regulatory verification. The contract should specify whether substitutions are prohibited or allowed under defined conditions.
41. Who is responsible for import VAT/GST?
The responsibility depends on the delivery term, local tax law, importer arrangement, and contract. The buyer should confirm the applicable tax treatment with the destination-country customs or tax adviser.
42. Who is responsible for customs clearance?
The parties should identify the exporter responsible for Indian export clearance and the importer responsible for destination import clearance. The selected Incoterm and contract should allocate any additional customs-broker and handling responsibilities.
43. Does Nawinza OPC guarantee customs clearance or regulatory approval?
No unconditional guarantee should be assumed. Customs release and regulatory approvals depend on competent authorities, product eligibility, accurate documentation, and compliance with applicable requirements. Any specific service commitment must be expressly agreed in writing.
44. Can a buyer request certificates before paying?
The buyer may request relevant available documents for review before placing an order or making payment, subject to confidentiality, supplier authorisation, and document availability. The parties should agree which documents will be supplied at each stage.
45. Can a buyer verify the manufacturer independently?
Yes. Buyers should use official regulator records, manufacturer contact details, certificate-issuing authorities, and other reliable verification channels where available. Verification should relate to the actual manufacturer, product, manufacturing site, and relevant batch where applicable.
46. What if the buyer’s import licence or product registration is delayed?
The parties should follow the agreed conditions precedent, procurement and payment milestones, extension procedure, and cancellation or refund terms. Shipment should not proceed until the legally required permissions are in place.
47. Are controlled medicines available for export?
Controlled medicines require product-specific assessment and may be subject to strict restrictions, special permits, or prohibitions. No availability should be assumed until the relevant authorities’ requirements and the eligibility of all parties have been confirmed.
48. What is a pharmaceutical supply agreement?
A pharmaceutical supply agreement is a contract defining the parties, products, quantities, prices, delivery terms, payment obligations, regulatory responsibilities, quality requirements, documentation, liability, and dispute resolution.
49. Should buyers and sellers sign a separate quality agreement?
A separate quality agreement may be appropriate for regulated, complex, or repeat transactions. It can define responsibilities for specifications, batch release, complaints, deviations, recalls, change control, storage, and other quality matters.
50. How can an international buyer start a pharmaceutical export enquiry with Nawinza OPC?
Send the product name, strength, dosage form, required quantity, destination country, preferred brand or manufacturer, and required documentation to nawinza2026@gmail.com or contact +91 7709102335 on WhatsApp. You can also visit www.nawinza.com.
Nawinza OPC will assess the enquiry according to the agreed scope, supplier availability, applicable regulations, and commercial feasibility. Any supply commitment will be subject to written confirmation.
Request a Pharmaceutical Export Quotation from India
Are you an international pharmaceutical importer, wholesaler, distributor, healthcare procurement company, or pharmaceutical business looking to source medicines from India?
Contact Nawinza OPC with your product specifications and destination requirements. We welcome eligible B2B enquiries for pharmaceutical sourcing, bulk supply, export coordination, and relevant private-label or OEM requirements, subject to availability and regulatory feasibility.
Buyer Enquiry Format
Please include the following details in your enquiry:
Company name and country.
Contact person’s name and business email.
Product or generic name.
Requested brand or manufacturer.
Strength and dosage form.
Pack size and quantity.
Destination country and delivery location.
Product registration or import authorisation status, where applicable.
Required certificates and documents.
Minimum remaining shelf life.
Preferred Incoterm and shipping method.
Target price, currency, and payment preference.
Expected delivery schedule.
Any special storage, labelling, or packaging requirements.
Contact Nawinza OPC
Nawinza OPC Pvt Ltd
Website: www.nawinza.com
Email: nawinza2026@gmail.com
WhatsApp / Mobile: +91 7709102335
Business enquiries: Pharmaceutical sourcing, B2B supply, export coordination, bulk requirements, and eligible private-label or OEM enquiries.
Please provide complete and accurate information so your requirements can be evaluated efficiently.
Disclaimer and Important Business Conditions
The information on this page is intended for general business information and preliminary enquiry purposes. It does not constitute legal, medical, pharmaceutical, tax, customs, or regulatory advice.
Product categories and service descriptions do not constitute confirmation of stock, pricing, manufacturer authorisation, product registration, or export eligibility. All product offers are subject to verification, supplier confirmation, applicable law, and written commercial agreement.
The buyer is responsible for providing accurate requirements and establishing the destination country’s import and market-entry requirements, except where a specific obligation is expressly assigned to another party by a lawful written agreement. Each party remains responsible for its own legal and regulatory obligations.
Any stated lead times, shipping costs, product availability, prices, certificates, or delivery estimates should be confirmed in writing before an order is accepted. Regulatory requirements, customs procedures, taxes, and trade restrictions may change.
No information on this page should be interpreted as a representation that every product is approved for use or sale in every country. Medicines must be supplied, imported, stored, distributed, and used in accordance with applicable laws and authorised product information.
A binding transaction should be governed by the applicable purchase order, accepted quotation, supply agreement, and any relevant quality or regulatory agreements. The parties should obtain professional advice where necessary before entering into a significant transaction.
Pharmaceutical Export from India Bulk Orders, Quotations and Shipping
Pharmaceutical Medicine Categories for Export from India
The following is a broad reference of generic medicines and example formulations that buyers may enquire about from Indian suppliers. These are examples for product-catalogue development, not confirmation of current stock or export eligibility. Each product must be checked against supplier availability, applicable licences, destination-country registration, and export restrictions.
1. Steroids and Corticosteroids
Description: Corticosteroids reduce inflammation and immune-system activity in certain conditions. They are distinct from anabolic-androgenic steroids, which have different uses and risks.
Medicine category | Generic medicine examples | Example formulation / strength |
|---|---|---|
Oral corticosteroids | Prednisolone | Tablets, e.g. 5 mg, 10 mg |
Systemic corticosteroids | Dexamethasone | Tablets or injections; strength varies by product |
Corticosteroids | Hydrocortisone | Tablets, injections, creams |
Anti-inflammatory corticosteroids | Methylprednisolone | Tablets, injections |
Inhaled corticosteroids | Budesonide | Inhalation products, nasal preparations |
Topical corticosteroids | Betamethasone | Creams, ointments, lotions |
Topical corticosteroids | Clobetasol propionate | Creams, ointments, scalp preparations |
Buyer specifications: Active ingredient, strength, dosage form, pack size, manufacturer, approved indication, destination, and any special import requirements.
Important: Corticosteroids can have significant adverse effects. Anabolic steroids require separate regulatory assessment and must not be treated as ordinary wellness products.
2. Painkillers and Analgesics
Description: Analgesics are medicines used to relieve pain. They include non-opioid pain relievers, anti-inflammatory medicines, and certain prescription-only or controlled medicines.
Medicine group | Generic medicine examples | Example formulation / strength |
|---|---|---|
Non-opioid analgesic | Paracetamol (acetaminophen) | Tablets, e.g. 500 mg |
NSAID | Ibuprofen | Tablets, e.g. 200 mg, 400 mg |
NSAID | Diclofenac | Tablets, topical gels, injections |
NSAID | Naproxen | Tablets, e.g. 250 mg, 500 mg |
Selective COX-2 inhibitor | Etoricoxib | Tablets, various strengths |
NSAID | Aceclofenac | Tablets, commonly 100 mg |
Local anaesthetic | Lidocaine (lignocaine) | Topical preparations, injections |
Opioid analgesic | Tramadol | Prescription-controlled status varies by jurisdiction |
Important: Opioids and certain other pain medicines may be subject to additional controls, prescribing restrictions, or import permits. They require separate eligibility checks.
3. Blood Pressure Medicines — Antihypertensives
Description: These medicines are used to manage high blood pressure and, in some cases, related cardiovascular conditions.
Medicine group | Generic medicine examples | Example formulation / strength |
|---|---|---|
ACE inhibitor | Ramipril | Capsules or tablets, e.g. 2.5 mg, 5 mg |
ARB | Telmisartan | Tablets, e.g. 20 mg, 40 mg, 80 mg |
ARB | Losartan | Tablets, e.g. 25 mg, 50 mg |
Calcium-channel blocker | Amlodipine | Tablets, e.g. 2.5 mg, 5 mg |
Beta blocker | Metoprolol | Immediate- or extended-release tablets |
Beta blocker | Bisoprolol | Tablets, various strengths |
Diuretic | Hydrochlorothiazide | Tablets, including combination products |
Diuretic | Chlorthalidone | Tablets, various strengths |
Combination products may contain two or more active ingredients, such as an ARB plus a calcium-channel blocker. The exact composition must be verified for each registered product.
4. Cardiac and Cardiovascular Medicines
Description: This category includes medicines used for selected heart conditions, angina, heart failure, abnormal heart rhythms, and prevention of cardiovascular events.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Antiplatelet | Aspirin (acetylsalicylic acid) | Tablets, including low-dose presentations |
Antiplatelet | Clopidogrel | Tablets, commonly 75 mg |
Anticoagulant | Apixaban | Tablets, various strengths |
Statin | Atorvastatin | Tablets, e.g. 10 mg, 20 mg |
Heart-failure medicine | Sacubitril/valsartan | Tablets, combination strengths |
Antianginal | Isosorbide mononitrate | Immediate- or extended-release tablets |
Antiarrhythmic | Amiodarone | Tablets or injections |
Cardiac glycoside | Digoxin | Tablets or oral liquid, where available |
Important: Anticoagulants, antiarrhythmics, and other cardiac medicines require particular attention to product registration, prescribing restrictions, product quality, and safe handling.
5. Diabetes and Blood Glucose Management
Description: Antidiabetic medicines help manage blood glucose in different forms of diabetes. Product selection depends on the patient’s condition, the medicine’s approved indication, and clinician assessment.
Medicine group | Generic medicine examples | Example formulation / strength |
|---|---|---|
Biguanide | Metformin | Tablets, commonly 500 mg, 850 mg, 1,000 mg |
Sulfonylurea | Glimepiride | Tablets, commonly 1 mg, 2 mg |
DPP-4 inhibitor | Sitagliptin | Tablets, commonly 50 mg, 100 mg |
DPP-4 inhibitor | Vildagliptin | Tablets, commonly 50 mg |
SGLT2 inhibitor | Dapagliflozin | Tablets, commonly 5 mg, 10 mg |
SGLT2 inhibitor | Empagliflozin | Tablets, commonly 10 mg, 25 mg |
Thiazolidinedione | Pioglitazone | Tablets, commonly 15 mg, 30 mg |
GLP-1 receptor agonist | Semaglutide | Injectable or oral presentations, depending on product |
Insulin | Human insulin and insulin analogues | Vials, cartridges, prefilled pens |
Buyer note: Insulin and other temperature-sensitive products may require a validated cold chain, monitoring, and appropriate storage documentation.
6. Thyroid Medicines
Description: Thyroid medicines include hormone replacement for an underactive thyroid and medicines used to treat an overactive thyroid.
Medicine group | Generic medicine examples | Example formulation / strength |
|---|---|---|
Thyroid hormone replacement | Levothyroxine sodium | Tablets, e.g. 25, 50, 75, 100 micrograms |
Thyroid hormone | Liothyronine sodium | Tablets, where authorised |
Antithyroid medicine | Carbimazole | Tablets, various strengths |
Antithyroid medicine | Methimazole (thiamazole) | Tablets, where authorised |
Antithyroid medicine | Propylthiouracil | Tablets, where authorised |
Important: Thyroid hormone replacement and antithyroid medicines are not interchangeable. Product availability and permitted strengths vary by market.
7. Anxiety and Mental Health Medicines
Description: This category includes medicines used for anxiety disorders and certain other mental health conditions. Different medicines have different indications, onset of action, and safety profiles.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
SSRI antidepressant | Sertraline | Tablets, commonly 25 mg, 50 mg |
SSRI antidepressant | Escitalopram | Tablets, commonly 5 mg, 10 mg |
SSRI antidepressant | Fluoxetine | Capsules or tablets, commonly 20 mg |
SNRI antidepressant | Venlafaxine | Immediate- or extended-release presentations |
SNRI antidepressant | Duloxetine | Delayed-release capsules |
Anxiolytic | Buspirone | Tablets, various strengths |
Benzodiazepine | Lorazepam | Tablets or other authorised forms |
Benzodiazepine | Clonazepam | Tablets or orally disintegrating presentations |
Important: Benzodiazepines can cause dependence, sedation, and withdrawal problems and may be controlled medicines. They should be listed and supplied only where legally permitted.
8. Women’s Healthcare and Gynaecology
Description: Women’s healthcare includes products used in contraception, menstrual and hormonal conditions, menopause management, reproductive health, and certain gynaecological infections.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Combined hormonal contraceptive | Ethinylestradiol with levonorgestrel | Tablets, combination-specific strengths |
Progestogen | Norethisterone | Tablets, various strengths |
Progestogen | Medroxyprogesterone acetate | Tablets or injections, depending on product |
Progesterone | Micronised progesterone | Capsules or other authorised forms |
Menopause hormone therapy | Estradiol | Tablets, patches, gels |
Fertility medicine | Letrozole | Tablets, commonly 2.5 mg; use depends on indication and local authorisation |
Uterotonic | Oxytocin | Injection, where authorised |
Antifungal | Clotrimazole | Vaginal tablets, creams |
Iron supplementation | Ferrous salts | Tablets, capsules, oral liquids |
Important: Hormonal medicines and fertility products have indication-specific restrictions. Products for pregnancy-related care may require additional controls and professional oversight.
9. Erectile Dysfunction and Men’s Sexual Health
Description: Medicines in this category may be used for erectile dysfunction and certain other men’s health conditions.
Medicine group | Generic medicine examples | Example formulation / strength |
|---|---|---|
PDE5 inhibitor | Sildenafil | Tablets, commonly 25 mg, 50 mg, 100 mg |
PDE5 inhibitor | Tadalafil | Tablets, commonly 5 mg, 10 mg, 20 mg, depending on indication |
PDE5 inhibitor | Vardenafil | Tablets, where authorised |
PDE5 inhibitor | Avanafil | Tablets, where authorised |
Androgen replacement | Testosterone formulations | Gels, injections, or other authorised forms |
Alpha blocker for urinary symptoms | Tamsulosin | Capsules or modified-release tablets |
Important: Sildenafil and related medicines can interact dangerously with nitrate medicines. Testosterone products may have additional prescribing, monitoring, and import restrictions. Availability must be verified by market.
10. Alcohol Dependence Treatment
Description: This category includes medicines used as part of professionally supervised treatment for alcohol dependence. These are different from products marketed as general detoxification or wellness supplements.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Opioid receptor antagonist | Naltrexone | Tablets; injectable formulations in some markets |
Alcohol dependence treatment | Acamprosate calcium | Delayed-release tablets |
Alcohol deterrent | Disulfiram | Tablets, where authorised |
Nutritional support | Thiamine (vitamin B1) | Tablets or injections, depending on product |
Vitamin supplementation | Folic acid | Tablets or other authorised presentations |
Important: These medicines are not substitutes for emergency treatment of severe alcohol withdrawal. Appropriate product selection and supervision are necessary.
11. Nerve Pain and Neuropathic Pain
Description: Neuropathic pain medicines are used for certain pain conditions involving nerve injury or abnormal nerve signalling.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Neuropathic pain medicine | Pregabalin | Capsules or tablets, various strengths |
Neuropathic pain medicine | Gabapentin | Capsules, tablets, oral solution |
SNRI | Duloxetine | Delayed-release capsules |
Tricyclic antidepressant | Amitriptyline | Tablets, various strengths |
Sodium-channel blocker | Carbamazepine | Tablets or extended-release presentations |
Topical local anaesthetic | Lidocaine | Patches or topical products, where authorised |
Important: Pregabalin and some other medicines may be subject to controlled-prescription requirements. The buyer must verify destination-country rules before requesting supply.
12. Cholesterol and Lipid-Lowering Medicines
Description: These medicines help manage elevated cholesterol or triglycerides and reduce cardiovascular risk in eligible patients.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Statin | Atorvastatin | Tablets, commonly 10–80 mg presentations |
Statin | Rosuvastatin | Tablets, commonly 5 mg, 10 mg, 20 mg |
Statin | Simvastatin | Tablets, various strengths |
Cholesterol absorption inhibitor | Ezetimibe | Tablets, commonly 10 mg |
Fibrate | Fenofibrate | Tablets or capsules, formulation-specific strengths |
Bile-acid sequestrant | Colesevelam | Tablets or other authorised presentations |
PCSK9 inhibitor | Evolocumab | Injection, where authorised |
Combination lipid-lowering therapy | Ezetimibe with a statin | Tablets, combination-specific strengths |
Some lipid-lowering medicines are oral products, while others are specialist injectable products. The specific presentation and regulatory status should be checked for the destination.
13. Dermatology, Anti-Acne and Skin-Care Medicines
Description: Dermatological medicines are used for conditions affecting the skin, including acne, fungal infections, eczema, psoriasis, and selected inflammatory disorders.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Topical retinoid | Tretinoin | Cream or gel, various concentrations |
Topical retinoid | Adapalene | Gel or cream, commonly 0.1% |
Topical antibacterial | Clindamycin | Gel, lotion, or other authorised topical form |
Acne treatment | Benzoyl peroxide | Gel or wash, various concentrations |
Oral retinoid | Isotretinoin | Capsules, various strengths |
Topical corticosteroid | Mometasone furoate | Cream, ointment, lotion |
Topical antifungal | Ketoconazole | Cream, shampoo |
Antifungal | Terbinafine | Cream or tablets, depending on product |
Psoriasis treatment | Calcipotriol | Cream or ointment, where authorised |
Barrier and skin protection | Zinc oxide | Creams, ointments |
Important: Isotretinoin has significant pregnancy-related risks and requires strict regulatory controls in many markets. Topical corticosteroids and combination creams also require careful classification and labelling.
Acne, Derma Creams and Combination Products
Buyers may enquire about creams, gels, lotions, ointments, shampoos, and other dermatological presentations. For combination products, specify every active ingredient and concentration.
A product marketed as a cosmetic skin cream is not necessarily a pharmaceutical medicine. Classification depends on its composition, claims, intended use, and destination-country law.
14. Hair-Care and Hair-Loss Medicines
Description: This category includes medicines and topical products used for certain types of hair loss and scalp conditions.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Hair-loss treatment | Minoxidil | Topical solution or foam, commonly 2% or 5% |
5-alpha-reductase inhibitor | Finasteride | Tablets, commonly 1 mg or 5 mg for different indications |
5-alpha-reductase inhibitor | Dutasteride | Capsules, commonly 0.5 mg |
Antifungal scalp treatment | Ketoconazole | Shampoo, formulation-specific concentration |
Scalp anti-inflammatory treatment | Clobetasol propionate | Scalp solution, foam, or other authorised form |
Important: Medicines for hair loss have different indications and risk profiles. Finasteride and dutasteride may be prescription-only and require appropriate precautions. Minoxidil products must be classified according to their specific formulation and approved claims.
15. Anti-Asthmatic and Respiratory Medicines
Description: Respiratory medicines include bronchodilators and anti-inflammatory treatments used for asthma and selected obstructive airway conditions.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Short-acting bronchodilator | Salbutamol (albuterol) | Inhaler, nebuliser solution |
Long-acting bronchodilator | Formoterol | Inhalation products |
Inhaled corticosteroid | Budesonide | Inhaler, nebuliser suspension |
Inhaled corticosteroid | Beclometasone | Metered-dose inhaler |
Combination inhaler | Budesonide with formoterol | Inhaler, combination-specific strengths |
Combination inhaler | Fluticasone with salmeterol | Inhaler, combination-specific strengths |
Leukotriene receptor antagonist | Montelukast | Tablets, chewable tablets, granules |
Anticholinergic bronchodilator | Ipratropium bromide | Inhaler or nebuliser solution |
Mucolytic | Acetylcysteine | Oral or inhaled forms, depending on product |
Important: Inhalers require suitable device packaging and product-specific labelling. Some respiratory medicines are maintenance treatments, while others are used for rapid symptom relief; they are not interchangeable.
16. Antiparasitic Medicines
Description: Antiparasitic medicines target particular parasites. The appropriate medicine depends on the parasite, disease, patient characteristics, and local treatment guidance.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Anthelmintic | Albendazole | Tablets, commonly 400 mg presentations |
Anthelmintic | Mebendazole | Tablets or oral suspension |
Anthelmintic | Ivermectin | Tablets or other authorised formulations |
Antiprotozoal | Metronidazole | Tablets, oral liquids, or injections |
Antimalarial | Artemether with lumefantrine | Tablets, combination-specific strengths |
Antimalarial | Artesunate | Oral or injectable products, according to approved use |
Antimalarial | Chloroquine phosphate | Tablets, where authorised for relevant indications |
Antiprotozoal | Tinidazole | Tablets, various strengths |
Antiparasitic | Praziquantel | Tablets, where authorised |
Important: Antiparasitic products are not universally effective against all parasites. Antimalarial selection depends on the organism, resistance patterns, and destination-country guidance.
17. Anti-Seizure, Epilepsy, Fits and Convulsions Medicines
Description: Antiseizure medicines are used to control particular seizure disorders and may also have other approved indications.
Medicine group | Generic medicine examples | Example formulation |
|---|---|---|
Antiseizure medicine | Levetiracetam | Tablets, oral solution, injection |
Antiseizure medicine | Sodium valproate / valproic acid | Tablets, capsules, oral liquids, or other authorised forms |
Antiseizure medicine | Lamotrigine | Tablets, dispersible or chewable presentations |
Antiseizure medicine | Carbamazepine | Tablets, extended-release tablets, oral suspension |
Antiseizure medicine | Oxcarbazepine | Tablets or oral suspension |
Antiseizure medicine | Topiramate | Tablets or sprinkle capsules |
Antiseizure medicine | Phenytoin | Capsules, tablets, or injection |
Emergency seizure medicine | Midazolam | Selected buccal, nasal, or injectable presentations where authorised |
Emergency seizure medicine | Diazepam | Selected rectal or injectable presentations where authorised |
Important: Some antiseizure medicines require strict prescription controls. Valproate carries significant pregnancy-related risks, and benzodiazepines may be controlled. Export and import eligibility must be checked individually.
18. Antibiotics and Antibacterial Medicines
Description: Antibiotics treat certain bacterial infections. They do not treat viral infections such as the common cold. The correct medicine depends on the infection, susceptibility patterns, patient factors, and applicable treatment guidelines.
Antibiotic group | Generic medicine examples | Example formulation |
|---|---|---|
Penicillin | Amoxicillin | Capsules, tablets, oral suspension |
Penicillin combination | Amoxicillin with clavulanic acid | Tablets or oral suspension |
Cephalosporin | Cefixime | Tablets, capsules, oral suspension |
Cephalosporin | Cefuroxime | Tablets or other authorised presentations |
Cephalosporin | Ceftriaxone | Injection |
Macrolide | Azithromycin | Tablets, capsules, oral suspension |
Macrolide | Clarithromycin | Tablets or extended-release presentations |
Tetracycline | Doxycycline | Capsules or tablets |
Fluoroquinolone | Ciprofloxacin | Tablets or other authorised presentations |
Fluoroquinolone | Levofloxacin | Tablets or injections |
Nitroimidazole antibacterial | Metronidazole | Tablets, oral liquids, injections |
Carbapenem | Meropenem | Injection |
Glycopeptide | Vancomycin | Oral or injectable products, according to indication |
Sulfonamide combination | Sulfamethoxazole with trimethoprim | Tablets or oral suspension |
Important: Antibiotics require responsible use and are subject to antimicrobial stewardship. Certain antibiotics have special restrictions, and some injectable or hospital-use products require additional documentation and handling controls.
19. Additional Pharmaceutical Categories Worth Adding
To make the Nawinza OPC pharmaceutical catalogue more comprehensive for international buyers, consider adding these categories too.
Category | Description | Generic medicine examples |
|---|---|---|
Gastrointestinal medicines | Acid reflux, ulcers and related digestive disorders | Omeprazole, pantoprazole, esomeprazole |
Antiemetics | Prevention or treatment of nausea and vomiting | Ondansetron, metoclopramide |
Antifungals | Treatment of fungal infections | Fluconazole, clotrimazole, terbinafine |
Antivirals | Treatment of specific viral infections | Acyclovir, valacyclovir, selected other antivirals |
Anaesthetics | Local or general anaesthesia, depending on product | Lidocaine, bupivacaine, selected anaesthetic agents |
Blood and haematology medicines | Selected anaemia and blood-related conditions | Ferrous salts, folic acid, selected anticoagulants |
Bone health | Osteoporosis and related conditions | Alendronate, calcium and vitamin D products |
Urology | Selected urinary and prostate conditions | Tamsulosin, finasteride |
Eye care medicines | Selected ophthalmic conditions | Timolol, latanoprost, lubricating preparations |
Hospital and critical-care medicines | Medicines for specialist and hospital settings | Selected injectable medicines, subject to approvals |
Vaccines and biologicals | Prevention or treatment involving biological products | Product-specific vaccines and biological medicines |
Vitamins and nutritional supplements | Correction of certain nutrient deficiencies | Vitamin B complex, vitamin D, iron products |
These are additional catalogue categories, not a guarantee that every listed product is available or eligible for export.
20. Chemical Formula Examples for Your Medicine Reference
If by “formula” you mean the chemical molecular formula of the active ingredient, these are illustrative examples. They are different from the pharmaceutical formulation, such as a 500 mg tablet or a 5 mg/mL oral liquid.
Generic ingredient | Molecular formula of the stated ingredient | Example product strength |
|---|---|---|
Paracetamol | C₈H₉NO₂ | 500 mg tablet |
Ibuprofen | C₁₃H₁₈O₂ | 400 mg tablet |
Metformin (free base) | C₄H₁₁N₅ | 500 mg tablet as metformin hydrochloride |
Amlodipine (free base) | C₂₀H₂₅ClN₂O₅ | 5 mg tablet, commonly formulated as a salt |
Atorvastatin (free acid) | C₃₃H₃₅FN₂O₅ | 10 mg tablet, often supplied as atorvastatin calcium |
Sildenafil (free base) | C₂₂H₃₀N₆O₄S | 50 mg tablet, commonly supplied as sildenafil citrate |
Levothyroxine (free acid) | C₁₅H₁₁I₄NO₄ | 50 microgram tablet, commonly supplied as levothyroxine sodium |
Amoxicillin (free acid) | C₁₆H₁₉N₃O₅S | 500 mg capsule, formulation may use a salt |
Albendazole | C₁₂H₁₅N₃O₂S | 400 mg tablet |
Prednisolone | C₂₁H₂₈O₅ | 5 mg tablet |
Finasteride | C₂₃H₃₆N₂O₂ | 1 mg or 5 mg tablet, depending on indication |
Salbutamol (free base) | C₁₃H₂₁NO₃ | Inhaler strength is generally stated as delivered or metered dose |
Formula note: A product’s label strength does not always correspond directly to the mass of its free-base molecule. Salts, hydrates, esters, and other forms can have different molecular formulas. For a formal product database, record the exact active substance, chemical form, strength, and dosage form separately.
21. Can All These Medicines Be Exported from India?
No single list can guarantee export availability for every medicine. Indian export requirements and destination-country regulations must be assessed for the specific product and transaction.
The Central Drugs Standard Control Organisation (CDSCO) publishes guidance concerning drug export requirements and export-related permissions. The Drugs Rules also address export labelling and packaging requirements.
Before listing a medicine as export-ready, verify:
Manufacturer and applicable manufacturing authorisation.
Supplier and exporter eligibility.
Destination-country product registration and import permissions.
Applicable restrictions on controlled or prescription medicines.
Correct labelling, packaging, batch and expiry information.
Required certificates and quality documents.
Storage, cold-chain and transport conditions, where relevant.
Any additional product-specific export authorisation.
For regulatory references, see the official CDSCO website: CDSCO — Central Drugs Standard Control Organisation and the WHO ATC medicine classification
Pharmaceutical Export from India Medicines Drugs Bulk Supply Products and Therapeutic Categories,
Pharmaceutical Export from India | Medicines, Drugs & Bulk Supply – Nawinza OPC,
Pharmaceutical Products and Therapeutic Categories,
Steroids, Painkillers and Anti-Inflammatory Medicines,
Blood Pressure and Cardiovascular Medicines,
Diabetes and Thyroid Medicines,
Anxiety, Neuropathic Pain and Antiseizure Medicines,
Women’s Healthcare and Men’s Sexual Health,
Alcohol Dependence Treatment Medicines,
Cholesterol and Lipid-Lowering Medicines,
Dermatology, Acne and Hair-Care Medicines,
Respiratory and Anti-Asthmatic Medicines,
Antiparasitic, Antibiotic and Antifungal Medicines,
Gastrointestinal, Hospital and Other Pharmaceutical Products,
Generic Names, Strengths, Dosage Forms and Product Specifications,
Pharmaceutical Export Eligibility and Regulatory Compliance,
Bulk Pharmaceutical Enquiries and Quotations,
Pharmaceutical Export from India | Medicines, Drugs & Bulk Supply – Nawinza OPC
Priority | Country | Main SEO keywords to target |
|---|---|---|
1 | United States | pharmaceutical exporters from India to USA, Indian generic medicine supplier USA |
2 | United Kingdom | pharmaceutical export from India to UK, Indian generic medicine supplier UK |
3 | Nigeria | pharmaceutical exporters from India to Nigeria, wholesale medicines supplier Nigeria |
4 | South Africa | pharmaceutical export from India to South Africa, generic medicines supplier South Africa |
5 | Brazil | pharmaceutical exporters from India to Brazil, Indian medicine supplier Brazil |
6 | Canada | pharmaceutical export from India to Canada, generic medicine supplier Canada |
7 | Australia | pharmaceutical export from India to Australia, Indian pharmaceutical supplier Australia |
8 | United Arab Emirates | pharmaceutical export from India to UAE, medicines wholesale supplier UAE |
9 | Saudi Arabia | pharmaceutical export from India to Saudi Arabia, pharmaceutical importer Saudi Arabia |
10 | Kenya | pharmaceutical export from India to Kenya, wholesale pharmaceutical supplier Kenya |
11 | Tanzania | pharmaceutical export from India to Tanzania, Indian medicines supplier Tanzania |
12 | Ghana | pharmaceutical export from India to Ghana, generic medicine wholesaler Ghana |
13 | Uganda | pharmaceutical export from India to Uganda, pharmaceutical importer Uganda |
14 | Ethiopia | pharmaceutical export from India to Ethiopia, medicine supplier Ethiopia |
15 | Egypt | pharmaceutical export from India to Egypt, Indian pharmaceutical manufacturer Egypt |
16 | France | pharmaceutical export from India to France, pharmaceutical B2B supplier France |
17 | Germany | pharmaceutical export from India to Germany, pharmaceutical supplier Germany |
18 | Netherlands | pharmaceutical export from India to Netherlands, generic medicines supplier Netherlands |
19 | Ireland | pharmaceutical export from India to Ireland, pharmaceutical wholesale supplier Ireland |
20 | Mexico | pharmaceutical export from India to Mexico, Indian medicines exporter Mexico |
21 | Colombia | pharmaceutical export from India to Colombia, pharmaceutical importer Colombia |
22 | Chile | pharmaceutical export from India to Chile, generic medicine supplier Chile |
23 | Peru | pharmaceutical export from India to Peru, pharmaceutical exporter India Peru |
24 | Bangladesh | pharmaceutical export from India to Bangladesh, medicine wholesale supplier Bangladesh |
25 | Nepal | pharmaceutical export from India to Nepal, pharmaceutical supplier Nepal |
26 | Sri Lanka | pharmaceutical export from India to Sri Lanka, Indian medicines supplier Sri Lanka |
27 | Philippines | pharmaceutical export from India to Philippines, pharmaceutical wholesale supplier Philippines |
28 | Vietnam | pharmaceutical export from India to Vietnam, generic medicine supplier Vietnam |
29 | Indonesia | pharmaceutical export from India to Indonesia, pharmaceutical importer Indonesia |
30 | Malaysia | pharmaceutical export from India to Malaysia, pharmaceutical supplier Malaysia |
31 | Singapore | pharmaceutical export from India to Singapore, pharmaceutical B2B supplier Singapore |
32 | Thailand | pharmaceutical export from India to Thailand, generic medicines supplier Thailand |
33 | Japan | pharmaceutical export from India to Japan, Indian pharmaceutical exporter Japan |
34 | South Korea | pharmaceutical export from India to South Korea, pharmaceutical supplier South Korea |
35 | Iraq | pharmaceutical export from India to Iraq, pharmaceutical importer Iraq |
36 | Oman | pharmaceutical export from India to Oman, medicine wholesale supplier Oman |
37 | Qatar | pharmaceutical export from India to Qatar, pharmaceutical supplier Qatar |
38 | Kuwait | pharmaceutical export from India to Kuwait, Indian medicines exporter Kuwait |
39 | Bahrain | pharmaceutical export from India to Bahrain, pharmaceutical supplier Bahrain |
40 | Jordan | pharmaceutical export from India to Jordan, pharmaceutical importer Jordan |
41 | Morocco | pharmaceutical export from India to Morocco, pharmaceutical exporter India Morocco |
42 | Algeria | pharmaceutical export from India to Algeria, generic medicines supplier Algeria |
43 | Senegal | pharmaceutical export from India to Senegal, pharmaceutical supplier Senegal |
44 | Côte d’Ivoire | pharmaceutical export from India to Ivory Coast, medicine supplier Côte d’Ivoire |
45 | Rwanda | pharmaceutical export from India to Rwanda, pharmaceutical importer Rwanda |
46 | Zambia | pharmaceutical export from India to Zambia, wholesale medicines supplier Zambia |
47 | Zimbabwe | pharmaceutical export from India to Zimbabwe, pharmaceutical supplier Zimbabwe |
48 | Mozambique | pharmaceutical export from India to Mozambique, Indian medicine exporter Mozambique |
49 | Angola | pharmaceutical export from India to Angola, pharmaceutical importer Angola |
50 | Mauritius | pharmaceutical export from India to Mauritius, pharmaceutical wholesale supplier Mauritius
Keyword group Keyword pattern Main export pharmaceutical export from India to [Country] Supplier pharmaceutical supplier from India to [Country] Exporter Indian pharmaceutical exporter [Country] Medicines medicines exporter from India to [Country] Generic medicines generic medicine supplier in [Country] Wholesale pharmaceutical wholesale supplier [Country] Bulk orders bulk medicines supplier [Country] B2B buyers pharmaceutical B2B supplier [Country] Importers pharmaceutical importer in [Country] Distribution pharmaceutical distributor supplier [Country] Private label pharmaceutical private label supplier India [Country] OEM pharmaceutical OEM supplier India [Country] Tablets tablet medicine exporter India [Country] Capsules pharmaceutical capsules supplier India [Country] Syrups pharmaceutical syrup exporter India [Country] Injections injectable medicine exporter India [Country] Product sourcing pharmaceutical product sourcing India [Country] Quotations pharmaceutical export quotation India [Country] Business enquiries pharmaceutical export enquiry India [Country] Company searches Indian pharmaceutical export company serving [Country] |
1. Pharmaceutical medicines — dosage forms
These are the main pharmaceutical dosage-form categories to include on the website.
Sr. No. | Product category | Types and examples of products |
|---|---|---|
1 | Tablets | Uncoated, film-coated, sugar-coated, chewable, dispersible, effervescent, soluble, sublingual, buccal, enteric-coated, sustained-release and extended-release tablets |
2 | Capsules | Hard gelatin, hard-shell, soft gelatin, liquid-filled, immediate-release and modified-release capsules |
3 | Syrups | Pharmaceutical syrups, medicated oral syrups, sugar-free syrups and oral liquid preparations |
4 | Oral solutions | Oral solutions, drops, concentrated solutions and other liquid preparations |
5 | Suspensions | Oral suspensions, reconstitutable dry suspensions and other suspension formulations |
6 | Powders and granules | Oral powders, granules, sachets, effervescent powders and reconstitution powders |
7 | Injections | Injectable solutions, suspensions and other authorised parenteral preparations |
8 | Infusions | Intravenous infusion products and sterile infusion solutions, subject to product and market authorisation |
9 | Vials and ampoules | Sterile pharmaceutical products supplied in glass or other approved containers |
10 | Creams | Dermatological creams, moisturising formulations and medicated topical creams |
11 | Ointments | Medicated ointments, protective ointments and topical preparations |
12 | Gels | Topical gels, medicated gels and other authorised gel formulations |
13 | Lotions | Dermatological lotions and topical liquid preparations |
14 | Eye drops | Ophthalmic solutions and other approved ophthalmic preparations |
15 | Ear drops | Otic solutions and approved ear preparations |
16 | Nasal drops and sprays | Nasal solutions, sprays and other approved nasal formulations |
17 | Inhalers | Metered-dose inhalers, dry-powder inhalers and other authorised inhalation products |
18 | Nebuliser solutions | Inhalation solutions and suspensions for approved nebulisation use |
19 | Suppositories | Rectal suppositories and other authorised rectal dosage forms |
20 | Pessaries and vaginal products | Vaginal tablets, capsules, creams, gels and other authorised preparations |
21 | Transdermal patches | Medicinal patches and other approved transdermal systems |
22 | Oral strips | Oral dissolving films and other authorised oral film products |
23 | Mouthwash and gargles | Medicinal mouthwashes, gargles and oral rinses |
24 | Topical sprays | Medicated sprays and approved topical spray preparations |
25 | Dental preparations | Dental gels, oral-care preparations and approved dental pharmaceutical products |
26 | Reconstitution products | Dry powders and concentrates intended to be prepared according to authorised instructions |
27 | Specialised formulations | Modified-release, delayed-release and other specialised dosage forms where authorised |
28 | Other pharmaceutical forms | Additional registered dosage forms according to manufacturer capabilities and market requirements |
Buyer quotation information: Product or generic name, brand preference, strength, dosage form, pack size, quantity, target market, required shelf life, packaging preference and regulatory requirements.
2. Pharmaceutical therapeutic categories
These are broad product categories for a medicines catalogue. Inclusion does not imply that every product is available or eligible for export to every country.
Sr. No. | Therapeutic category | Product scope |
|---|---|---|
1 | Pain management | Analgesic and other authorised pain-management medicines |
2 | Anti-inflammatory medicines | Non-steroidal anti-inflammatory and other approved anti-inflammatory products |
3 | Antibiotics | Approved antibacterial medicines, subject to prescription and antimicrobial regulations |
4 | Antifungals | Medicines used for approved fungal infections |
5 | Antivirals | Approved antiviral medicines |
6 | Antiparasitic medicines | Anthelmintic and other authorised antiparasitic products |
7 | Antimalarial medicines | Approved antimalarial treatments |
8 | Cardiovascular medicines | Medicines for approved cardiovascular indications |
9 | Antihypertensives | Medicines used to manage high blood pressure |
10 | Diabetes medicines | Oral antidiabetic medicines and other approved diabetes therapies |
11 | Thyroid medicines | Approved thyroid-related treatments |
12 | Cholesterol management | Lipid-lowering medicines |
13 | Gastrointestinal medicines | Acid-reducing, antiemetic, antacid and other GI medicines |
14 | Respiratory medicines | Approved medicines for respiratory conditions |
15 | Antiallergy medicines | Antihistamines and other authorised allergy treatments |
16 | Dermatology | Approved dermatological medicines and topical preparations |
17 | Hair and scalp treatments | Registered medicinal hair and scalp products |
18 | Women’s healthcare | Approved women’s health and gynaecological products |
19 | Men’s healthcare | Approved men’s health products |
20 | Neurology | Medicines for authorised neurological indications |
21 | Antiseizure medicines | Approved anticonvulsant and antiseizure products |
22 | Mental health medicines | Authorised psychiatric medicines subject to controlled-drug rules where applicable |
23 | Bone and joint health | Approved musculoskeletal and bone-health medicines |
24 | Urology | Approved urological products |
25 | Eye care | Ophthalmic medicines and approved eye-care preparations |
26 | Ear, nose and throat | Approved ENT medicines and preparations |
27 | Hospital medicines | Approved medicines used in hospital and institutional settings |
28 | Emergency and critical care | Eligible emergency-care and critical-care medicines, subject to strict regulatory requirements |
29 | Anaesthesia | Authorised anaesthetic products subject to applicable controls |
30 | Oncology | Registered oncology products, subject to destination approval and specialised handling requirements |
31 | Immunology | Approved immune-related medicines |
32 | Vaccines and biologicals | Products subject to specific authorisation, cold-chain and handling requirements |
33 | Hormonal medicines | Approved hormonal preparations, subject to applicable regulations |
34 | Renal care | Approved products used in renal-care settings |
35 | Liver and metabolic health | Approved medicines for relevant indications |
36 | Nutritional products | Eligible medical nutrition and nutritional-support products |
37 | Vitamins and minerals | Registered supplements and medicinal vitamin or mineral products, as applicable |
38 | Oral and dental health | Approved dental and oral pharmaceutical products |
39 | Paediatric medicines | Age-appropriate registered formulations for children |
40 | Geriatric medicines | Approved products for older adult populations |
41 | Maternal healthcare | Eligible maternity-related healthcare products |
42 | Wound care | Approved medicinal wound-care preparations and related products |
43 | Antiseptics and disinfectants | Products for approved uses and relevant regulatory classifications |
44 | Alcohol-dependence treatment | Approved medicines subject to prescription and destination-country controls |
45 | Other therapeutic categories | Additional registered medicines according to buyer requirements |
3. Medical devices and equipment
Medical devices are distinct from pharmaceutical medicines. Their classification, registration, permitted claims and import requirements depend on the product and destination country.
Sr. No. | Category | Types and examples |
|---|---|---|
1 | Diagnostic equipment | Diagnostic instruments and eligible clinical testing equipment |
2 | Blood pressure monitors | Digital BP monitors, manual monitors, cuffs and accessories |
3 | Thermometers | Digital thermometers and other authorised temperature-measuring devices |
4 | Pulse oximeters | Fingertip and other approved oxygen-saturation monitoring devices |
5 | Glucose monitoring | Blood glucose meters, compatible test strips, lancets and accessories |
6 | Blood glucose lancets | Single-use lancets and compatible lancing accessories |
7 | Weighing equipment | Medical weighing scales and baby weighing scales |
8 | Stethoscopes | Acoustic and electronic stethoscopes |
9 | ECG equipment | Electrocardiographs, ECG cables, electrodes and accessories |
10 | Patient monitors | Multiparameter monitors and compatible accessories |
11 | Temperature and vital-sign equipment | Eligible clinical monitoring equipment |
12 | Nebulisers | Compressor and other approved nebuliser devices and accessories |
13 | Oxygen equipment | Eligible oxygen concentrators, flowmeters and related accessories |
14 | Respiratory support | Approved respiratory-care devices and accessories |
15 | Infusion equipment | Infusion pumps and related approved accessories |
16 | Syringes | Sterile disposable syringes and approved accessories |
17 | Needles | Hypodermic needles and other permitted medical needles |
18 | IV administration products | IV sets, extension sets, connectors and related products |
19 | Cannulas | Peripheral IV cannulas and compatible accessories |
20 | Catheters | Eligible urinary, suction and other medical catheter categories |
21 | Urine collection products | Urine bags and related collection accessories |
22 | Surgical instruments | Eligible reusable and single-use surgical instruments |
23 | Examination instruments | Diagnostic and examination instruments |
24 | Sterilisation equipment | Eligible sterilisation equipment and accessories |
25 | Surgical equipment | Approved surgical devices and related equipment |
26 | Patient beds | Hospital beds, examination beds and related accessories |
27 | Mobility aids | Wheelchairs, walkers, crutches and walking sticks |
28 | Patient support products | Transfer aids and other approved patient-care products |
29 | Orthopaedic products | Braces, supports, splints and eligible orthopaedic devices |
30 | Rehabilitation equipment | Eligible rehabilitation and physiotherapy equipment |
31 | Hearing and ENT devices | Approved hearing-related and ENT devices |
32 | Eye-care equipment | Approved ophthalmic instruments and accessories |
33 | Dental equipment | Eligible dental instruments, equipment and consumables |
34 | Laboratory equipment | Eligible laboratory instruments and equipment |
35 | Medical refrigeration | Approved medical refrigerators and related storage equipment |
36 | Medical furniture | Examination tables, trolleys, stools and storage units |
37 | Hospital trolleys | Medicine trolleys, instrument trolleys and patient transport products |
38 | Medical suction equipment | Suction machines and approved accessories |
39 | Defibrillators | Approved defibrillators and compatible consumables |
40 | Medical device accessories | Cables, probes, cuffs, sensors, chargers and compatible accessories |
4. Medical consumables and hospital supplies
Sr. No. | Category | Types and examples |
|---|---|---|
1 | Examination gloves | Nitrile, latex and other suitable examination gloves |
2 | Surgical gloves | Sterile surgical gloves |
3 | Face masks | Medical masks and other appropriately classified protective masks |
4 | Respirators | Approved particulate respirators |
5 | Protective clothing | Gowns, aprons, coveralls and related protective garments |
6 | Caps and shoe covers | Medical caps, shoe covers and other protective accessories |
7 | Gauze and dressings | Sterile gauze, non-woven dressings and wound dressings |
8 | Bandages | Crepe, conforming, elastic and other bandages |
9 | Adhesive products | Medical tapes, adhesive dressings and fixation products |
10 | Cotton products | Medical cotton wool, cotton rolls and swabs |
11 | Wound-care products | Eligible wound pads, dressings and wound-care accessories |
12 | First-aid supplies | First-aid kits and eligible first-aid components |
13 | Disposable syringes | Sterile single-use syringes in appropriate specifications |
14 | Blood collection | Approved blood collection tubes, holders and related consumables |
15 | Specimen containers | Urine, stool and other approved specimen containers |
16 | Laboratory consumables | Pipette tips, tubes, slides and other eligible laboratory supplies |
17 | IV consumables | IV sets, connectors, extension tubing and other approved products |
18 | Surgical disposables | Eligible single-use surgical products |
19 | Suction consumables | Suction catheters, tubing and related accessories |
20 | Patient hygiene | Underpads, disposable wipes and eligible hygiene products |
21 | Adult incontinence | Adult diapers, briefs and absorbent products |
22 | Baby care | Baby diapers, wipes and baby-hygiene products |
23 | Maternity supplies | Maternity pads and eligible maternity-care products |
24 | Urinary care | Eligible urine bags and urinary-care accessories |
25 | Infection prevention | Approved infection-prevention consumables |
26 | Sterilisation packaging | Medical sterilisation pouches and compatible packaging |
27 | Medical waste products | Sharps containers and eligible clinical waste containers |
28 | Hospital linen | Eligible medical sheets, pillow covers and related linen |
29 | Patient care disposables | Bibs, drapes and other approved disposable care products |
30 | Other hospital supplies | Additional consumables according to institutional requirements |
5. Diagnostic tests, laboratory products and rapid test kits
Sr. No. | Product category | Examples |
|---|---|---|
1 | Clinical chemistry | Approved clinical chemistry reagents and analyser consumables |
2 | Haematology | Approved haematology reagents and compatible consumables |
3 | Urinalysis | Urine test strips and eligible urinalysis supplies |
4 | Pregnancy testing | Authorised pregnancy test kits |
5 | Infectious disease tests | Approved diagnostic test kits, subject to local registration |
6 | Glucose testing | Blood glucose test strips and related products |
7 | Cholesterol testing | Approved lipid-testing kits and consumables |
8 | Electrolyte testing | Eligible electrolyte reagents and analyser consumables |
9 | Laboratory reagents | Approved reagents and laboratory chemicals for their permitted uses |
10 | Specimen collection | Swabs, specimen tubes and collection accessories |
11 | Microscopy supplies | Slides, cover slips and other laboratory accessories |
12 | Rapid diagnostic products | Eligible rapid tests according to destination-country authorisation |
13 | Laboratory instruments | Eligible analysers, centrifuges and laboratory instruments |
14 | Diagnostic accessories | Controls, calibrators and other compatible authorised supplies |
Diagnostic kits must not be advertised as available for a particular country unless the relevant product registration, intended use and import requirements have been checked.
6. Other healthcare product categories
Sr. No. | Category | Products |
|---|---|---|
1 | Vitamins and nutrition | Eligible vitamin, mineral and nutritional products |
2 | Medical nutrition | Approved oral nutritional supplements and specialised nutrition products |
3 | Personal care | Cleansers, moisturisers, lotions and hygiene products |
4 | Skin care | Eligible skincare and dermatological products |
5 | Oral care | Toothbrushes, toothpaste, mouthwash and dental hygiene products |
6 | Baby care | Baby toiletries, diapers, wipes and infant-care accessories |
7 | Mother and maternity care | Nursing pads, maternity pads and maternity accessories |
8 | Elderly care | Adult incontinence products and daily-living aids |
9 | Home healthcare | Home monitoring equipment and eligible home-care supplies |
10 | First aid | First-aid kits and related supplies |
11 | Ayurveda and herbal wellness | Eligible traditional wellness and herbal products |
12 | Medical-grade hygiene | Products classified and authorised for the intended use |
13 | Pet healthcare | Eligible veterinary medicines, animal-care supplies and pet hygiene products |
14 | Veterinary devices | Eligible veterinary diagnostic devices and clinical consumables |
15 | Hospital cleaning | Suitable cleaning and hygiene supplies for healthcare facilities |
16 | Healthcare packaging | Eligible bottles, closures, blister packaging and other packaging supplies |
7. B2B export and supply services
Sr. No. | Service | Description |
|---|---|---|
1 | Pharmaceutical sourcing | Enquiries for eligible medicines from Indian manufacturers and suppliers |
2 | Medical device sourcing | Sourcing of eligible medical devices and healthcare equipment |
3 | Wholesale enquiries | Product and price enquiries for wholesale procurement |
4 | Bulk supply enquiries | Larger-volume enquiries subject to supplier capacity |
5 | Manufacturer sourcing | Identification and evaluation of suitable suppliers |
6 | Private label | Enquiries for eligible products under a buyer’s brand, subject to permissions and agreements |
7 | OEM sourcing | Original equipment manufacturer enquiries for suitable product categories |
8 | Product specifications | Collection and confirmation of product, packaging and technical specifications |
9 | Export documentation coordination | Coordination of applicable commercial and export documents |
10 | International logistics coordination | Shipping and delivery coordination according to the agreed terms |
11 | Destination-market checks | Review of relevant import and product-registration requirements |
12 | Quotation support | Quotations based on confirmed product, quantity, destination and terms |
13 | Institutional supply | Enquiries from eligible hospitals, clinics, laboratories and other institutions |
14 | Distributor enquiries | Enquiries from importers, wholesalers and distributors |
15 | Repeat procurement | Repeat-order coordination based on product availability and approved terms |
8. Information international buyers should provide
To help Nawinza process enquiries efficiently, ask buyers to provide:
Product name and generic name, where applicable
Dosage form or medical device type
Strength, size, model or technical specifications
Brand preference or manufacturer requirement
Pack size and packaging preference
Required quantity
Destination country and delivery city or port
Required registration, certification or import documentation
Desired delivery schedule
Private-label or OEM requirements, if applicable
Preferred Incoterm, such as EXW, FCA, FOB or CIF, where suitable
Company name and business contact details
9. Regulatory and product availability disclaimer
Product Availability, Regulatory Compliance and Export Disclaimer
The product categories listed on this page describe the scope of products for which Nawinza OPC Pvt Ltd may receive sourcing, supply and export enquiries. Listing a product category does not guarantee stock availability, manufacturer appointment, distribution rights, product registration, export permission or eligibility for import into any particular country.
All pharmaceutical products, medical devices, diagnostic kits, veterinary products and other regulated healthcare goods are subject to applicable Indian laws, manufacturer permissions, export requirements, product registrations, import permits and destination-country regulations. Prescription medicines, controlled substances, biological products, vaccines, injectables and other specially regulated products may be subject to additional restrictions, storage conditions, documentation or licensing.
Product specifications, manufacturer details, pricing, minimum order quantities, packaging, shelf life, certificates and delivery schedules must be confirmed individually before an order is accepted. Private-label and OEM arrangements depend on manufacturer capability, contractual permissions and applicable legal requirements.
Nawinza OPC Pvt Ltd does not represent that every listed product is approved or available in every market. Buyers are responsible for providing accurate destination and import requirements, and all parties must comply with the laws and regulations applicable to their transaction.
Disclaimer: Export Documentation, Regulatory Compliance, Buyers and Sellers
Nawinza OPC Pvt Ltd — Pharmaceutical Products, Medical Devices, Healthcare Supplies and International Trade
All products, product categories, specifications, services and export-related information displayed on www.nawinza.com are provided for general business information and B2B enquiry purposes only. Listing any product does not guarantee its availability, approval, registration, export eligibility, import eligibility or permission to sell in any country.
1. Export and Import Compliance
All exports, imports, cross-border transactions and international supplies must comply with applicable laws, rules, regulations, notifications, licensing conditions and government requirements in India and the destination country, including any applicable transit or re-export requirements.
Compliance requirements may include, as applicable, export authorisations, import permits, product registration, manufacturing licences, drug licences, medical device registration, customs clearance, applicable duties and taxes, foreign trade requirements, sanctions restrictions and other regulatory approvals.
2. Responsibility of Buyers and Importers
Every buyer, importer, distributor, wholesaler, institution or other purchaser is responsible for independently verifying the legal requirements applicable to the intended purchase, importation, distribution, marketing, storage and sale of the products in the destination country.
Before placing an order, buyers must confirm that they hold the necessary licences, permits, registrations, authorisations and other approvals required by the relevant authorities. Buyers must also ensure that the products can legally be imported, received, stored, marketed and distributed in their territory.
3. Responsibility of Sellers, Manufacturers and Exporters
Every seller, manufacturer, supplier, exporter or other supplying party is responsible for complying with the laws and regulatory requirements applicable to its activities and products. These responsibilities may include maintaining valid licences and authorisations, supplying genuine and legally eligible products, providing accurate product information, maintaining applicable quality and traceability records, and preparing the documents required for the transaction.
Where applicable, supplying parties must ensure that products meet relevant quality, labelling, packaging, shelf-life, storage, transport and safety requirements.
4. Verification of Documents and Certificates
All parties must verify the authenticity, validity, accuracy, completeness and applicability of relevant documents before shipment, customs clearance, importation or distribution.
Depending on the product and transaction, documents may include commercial invoices, packing lists, purchase orders, shipping documents, certificates of origin, applicable export declarations, import permits, product registration documents, manufacturing or marketing authorisations, certificates of analysis, batch documents, quality certificates, safety data sheets, insurance documents and other certificates or declarations required by the relevant authorities or contractual terms.
No document or certificate should be assumed to be mandatory, sufficient, valid or acceptable for every product or destination. Requirements must be confirmed with the competent authorities, customs authorities, relevant regulatory agencies and qualified professionals, as applicable.
5. Pharmaceutical Products and Medical Devices
Medicines, active pharmaceutical ingredients, medical devices, diagnostic kits, biological products, vaccines, controlled medicines and other regulated healthcare products may be subject to additional restrictions, registration requirements, prescription controls, special handling conditions, temperature controls, traceability obligations and destination-specific approvals.
No pharmaceutical product or medical device should be shipped solely on the basis of its appearance on this website or the availability of a quotation. Product-specific export and import eligibility must be confirmed before the transaction proceeds.
6. Government Rules, Customs and Regulatory Changes
Government policies, export restrictions, import conditions, customs procedures, tax requirements, product classifications, tariffs, sanctions and regulatory standards may change without notice. All parties must verify the rules in force at the relevant time, including before order confirmation, payment, dispatch and customs clearance.
Product classifications and tariff codes, including HS codes, must be independently checked against the applicable product specifications and official tariff requirements. Any general information on this website should not be treated as a binding classification or official government determination.
7. Buyer and Seller Due Diligence
Buyers and sellers are responsible for conducting appropriate due diligence on their respective transaction counterparties, including business identity, licences, authorisations, banking details, product authenticity, commercial terms, payment arrangements and compliance status.
Both parties should agree in writing on product specifications, quantities, pricing, payment terms, Incoterms, delivery schedules, insurance, allocation of duties and taxes, document responsibilities, inspection procedures, claims, returns and dispute-resolution arrangements before confirming an order.
8. Role and Limitations of Nawinza OPC Pvt Ltd
Information published on this website is not a substitute for official regulatory advice, legal advice, customs advice, tax advice or product-specific technical assessment.
Nawinza OPC Pvt Ltd undertakes to assess enquiries and coordinate applicable checks and documentation within the agreed scope of a transaction. However, unless expressly agreed in writing and legally applicable, Nawinza does not guarantee that every product, supplier, buyer, certificate, shipment or proposed transaction will receive government approval, customs clearance, product registration or acceptance in the destination country.
The responsibilities of Nawinza OPC Pvt Ltd in a specific transaction shall be determined by the applicable law, relevant licences and authorisations, written agreements and the actual role undertaken by Nawinza in that transaction. Nothing in this disclaimer excludes any responsibility that cannot lawfully be excluded.
9. No Guarantee of Product Availability or Transaction Completion
Product descriptions, examples, categories, quotations, specifications, estimated delivery times and other information are indicative unless expressly confirmed in writing. Actual availability, pricing, lead times, minimum order quantities, shipping costs, documentation and regulatory requirements may vary by manufacturer, product, quantity and destination.
A product enquiry or quotation does not itself constitute an accepted order, an export authorisation, an import approval or a guarantee of delivery.
10. Indemnity and Limitation of Liability
To the extent permitted by applicable law and subject to any signed agreement, each buyer, seller, manufacturer, importer and exporter remains responsible for its own representations, actions, omissions, legal obligations and compliance failures.
No party should rely solely on general website information when making a regulated product or international trade decision. Any limitation of liability, indemnity or allocation of responsibility between transaction parties must be interpreted in accordance with applicable law and the relevant written agreement.
11. Acceptance of Disclaimer
By accessing this website, submitting an enquiry or engaging in a transaction with Nawinza OPC Pvt Ltd, users acknowledge that international trade and regulated products are subject to legal, documentary and compliance requirements. Each party must undertake the verification and due diligence appropriate to its role and must not proceed with a transaction unless the necessary legal requirements have been satisfied.
For product enquiries and B2B export discussions:
Company: Nawinza OPC Pvt Ltd
Website: www.nawinza.com
Email: nawinza2026@gmail.com
WhatsApp / Mobile: +91 7709102335